HomePH4 • FRA
add
CStone Pharmaceuticals
Previous close
€0.75
Year range
€0.20 - €1.35
Market cap
9.17B HKD
Avg Volume
1.61K
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
In the news
Financials
Income Statement
Revenue
Net income
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 24.73M | -80.54% |
Operating expense | 92.18M | 4.94% |
Net income | -135.09M | -1,821.02% |
Net profit margin | -546.37 | -8,940.94% |
Earnings per share | — | — |
EBITDA | -135.51M | -8,511.70% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 690.10M | -19.54% |
Total assets | 1.19B | -22.20% |
Total liabilities | 876.86M | -17.62% |
Total equity | 315.04M | — |
Shares outstanding | 1.36B | — |
Price to book | 3.24 | — |
Return on assets | -29.07% | — |
Return on capital | -49.04% | — |
Cash Flow
Net change in cash
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -135.09M | -1,821.02% |
Cash from operations | -137.16M | -46.59% |
Cash from investing | 47.43M | 197.06% |
Cash from financing | 125.07M | 805.17% |
Net change in cash | 34.91M | 121.97% |
Free cash flow | -75.18M | -1,394.83% |
About
Founded
2015
Website
Employees
131
